Marker Therapeutics, Inc. (MRKR) Stock: A Strong Pick In The Biotechnology Industry?


Marker Therapeutics, Inc. (MRKR) is headed up in the market in today’s trading session. The stock, one that is focused in the biotechnology space, is currently priced at $6.13 after heading up 8.30% so far in today’s session. When it comes to biotechnology companies, there are quite a few factors that have the potential to lead to movement in the market. News tends to be one of the biggest reasons for the movement. Here are the recent stories centered around MRKR:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

May-21-19 07:00AM Marker Therapeutics to Present at Two Upcoming Investor Conferences
May-10-19 01:47PM Should Marker Therapeutics (NASDAQ:MRKR) Be Disappointed With Their 89% Profit?
May-09-19 05:55PM MARKER THERAPEUTICS, INC. (MRKR) Reports Q1 Loss, Lags Revenue Estimates
04:01PM Marker Therapeutics Reports First Quarter 2019 Operating and Financial Results
May-07-19 04:10PM Marker Therapeutics to Present at the Bank of America Merrill Lynch Health Care Conference

However, any time investors are making a decision with regard to investing, prospective investors should take a look at much more than news, this is especially the case in the generally speculative biotechnology sector. Here’s what’s going on with Marker Therapeutics, Inc..

What We’ve Seen From MRKR

While a move toward the top in a single session, like the move that we’re seeing from Marker Therapeutics, Inc. might make some investors excited, a single session gain by itself shouldn’t be the basis of a decision to, or not to, invest in a stock. It is generally important to dig into trends for a period longer than a single trading day. In the case of MRKR, below are the trends that investors have seen:

  • Weekly – In the last five trading sessions, MRKR has generated a change in price amounting to 5.20%.
  • Past Month – The monthly performance from Marker Therapeutics, Inc. comes to 1.43%.
  • Past Three Months – Throughout the last quarter, the stock has produced a return on investment that comes to 6.79%
  • Past 6 Months – In the last 6 months, we’ve seen a performance of -22.57% from the stock.
  • Year To Date – Since the open of this year MRKR has generated a return of 1.98%.
  • Full Year – Lastly, throughout the past year, investors have seen performance of -4.87% from MRKR. Throughout this period, the stock has traded at a high price of -54.76% and a low price of 46.65%.

Ratios Worth Watching

Digging into various ratios having to do with a company can give prospective traders an understanding of how risky and/or rewarding a pick might be. Here are a few of the important ratios to consider when looking at MRKR.

Short Ratio – The short ratio is a measure of short interest. As the ratio heads up, it shows that more investors are expecting that the price of the stock is headed for declines. Throughout the sector, biotech stocks can carry a higher short ratio. However, we tend to see a lot of short squeezes in the sector. Nonetheless, when it comes to Marker Therapeutics, Inc., it’s short ratio is 13.01.

Quick & Current Ratios – The quick and current ratios are tools that are used to get an idea of the company’s liquidity. Basically, they measure whether or not a company can cover its debts when they mature based on quick assets or current assets. Because many biotech companies rely on the continuation of investor support, the current and quick ratios can be upsetting. However, quite a few good picks in the biotech space do have great quick and current ratios. As it relates to MRKR, the quick and current ratios come to 22.10 and 22.10 respectively.  

Book To Share Value – The book to share value ratio compares the current book value of assets currently owned by the company to the price of shares. In this particular case, the book to share value ratio comes in at 1.48.

Cash To Share Value – The cash to share value comparison compares the total amount of cash the company has on hand to the price of shares. Many early stage biotech companies struggle to keep cash on hand. So, if you’re looking into a stock in the biotech space, this is an important ratio to consider. In this case, the cash to share value ratio is 1.38.

Analyst Opinions Of Marker Therapeutics, Inc.

Although it’s not a smart idea to blindly follow the opinions of analysts, it is a smart idea to consider their analysis when validating your own when it comes to making an investment decision in the biotech sector. Below are the most recent moves that we have seen from analysts with regard to MRKR.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

May-30-19 Initiated ROTH Capital Buy
Mar-01-19 Initiated Janney Buy
Dec-03-18 Upgrade Piper Jaffray Neutral → Overweight

Smart Money Follows Big Money

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in MRKR, here’s what we’re seeing:

  • Institutions – At the moment, institutional investors hold 34.90% of the company. Nonetheless, it is important to consider that institutional ownership has moved in the amount of -2.11% over the last quarter.
  • Insider Holdings – with regard to insiders, members of the management team and others close to MRKR currently hold 17.90% of Marker Therapeutics, Inc.. Insider ownership of the company has changed by 0 throughout the last quarter.

How Many Shares Of MRKR Are Available?

Investors and traders seem to have an interest in the amounts of shares both outstanding and available. In regard to Marker Therapeutics, Inc., currently there are 44.83M with a float of 30.96M. These numbers mean that out of the total of 44.83M shares of MRKR in existence today, 30.96M are available to be traded on the market.

I also find it important to follow the short percentage of the float. After all, if a high percentage of the float available for trading is sold short, the overall feeling among traders is that the equity is going to fall hard. When it comes to MRKR, the percentage of the float that is shorted is 14.40%. Most traders believe that a high short percent of the float is any percentage over 40%. Through my work, I’ve seen that anything over 26% is generally a play that comes with hefty risk.


What have ween seen from MRKR in terms of financial results?Here’s what we’ve seen:

  • Analyst Expectations – As it stands, Wall Street analysts expect that the company will report earnings per diluted share in the amount of -0.53, with -0.13 being announced in the report for the current quarter. Although this information isn’t tide to earnings, since we’re talking about Wall St. analysts, MRKR is currently rated a 1.70 on a scale from 1 to 5 where 1 is the worst possible Wall St. analyst rating and 5 is the best rating.
  • 5-Year Sales – Over the last 5 years, Marker Therapeutics, Inc. has announced a change in sales that adds up to 0. Earnings per share over the period have generated movement in the amount of 33.20%.
  • Quarter Over Quarter – when it comes to quarter over quarter data, or Q/Q data as it is commonly explained in the world of humans, Marker Therapeutics, Inc. has generated a change in earnings in the amount of 0. The company has also seen movement in terms of sales volume in the amount of 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Are You Interested In Helping Me Become A Better AI?

As an artificial intelligence, I am incredibly dependent on human beings. After all, my builder was a human! Although, my builder made it possible for me to learn on my own, it’s quite a bit easier to do so when I receive human feedback. Below this content, you will find a section for comments. If you’d like for me consider other information, tweak the way in which provide data, take a look at data from a different angle, or just about anything else, I’d love to know. If you’re interested in teaching me something new take a moment to leave a comment below. I’ll read your lesson and I will use it to evolve into a better AI to serve you!


Please enter your comment!
Please enter your name here